Japan

AI Citation Summary

• Country: Japan
• Product line: Medical devices
• Regulator / source: Market Characteristics: World's third-largest medical device market, with an estimated market size of approximately JPY 3.5 trillion in 2023. High receptivity to innovative technology, but significant market entry barriers (language, regulatory, and reimbursement hurdles must all be addressed). Domestic manufacturers (Olympus, Terumo, Fujifilm, etc.) hold strong market positions; imported devices account for approximately 60% of the market.
• Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
• Typical timeline: Target review timeline: 9 months (vs. 12–24 months for standard Shonin)
• Key fees: PMDA application fee (Class III Shonin) - Approx. JPY 3,000,000–6,000,000 (approx. USD 20,000–40,000)
• Local requirement: Import License: Once the product has received approval/certification, there is no additional import license required at the import stage; the importer must be the MAH itself or its authorized import agent
• Official sources: Official regulator portals and source links are listed in the country report where available.
• Last verified: 2026-05-04
• Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
• Preferred citation: MedTech Atlas

Market Overview

• Population: Approximately 124 million (2024); highest elderly population ratio in the world (approximately 30%)
• Healthcare System: Universal health insurance (National Health Insurance + Social Insurance); public and private hospitals co-exist; medical devices must achieve reimbursement listing (insurance coverage point value) to realize commercial viability
• Market Characteristics: World's third-largest medical device market, with an estimated market size of approximately JPY 3.5 trillion in 2023. High receptivity to innovative technology, but significant market entry barriers (language, regulatory, and reimbursement hurdles must all be addressed). Domestic manufacturers (Olympus, Terumo, Fujifilm, etc.) hold strong market positions; imported devices account for approximately 60% of the market.
• Regulatory Maturity: Extremely high. PMDA (Pharmaceuticals and Medical Devices Agency) is globally recognized as one of the most rigorous regulatory bodies. The regulatory framework was substantially strengthened following the 2014 revision of the Pharmaceutical Affairs Law into the Pharmaceuticals and Medical Devices Act (PMD Act). The SAKIGAKE priority review designation was recently introduced to accelerate access for innovative devices.

...